UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
An accessible overview of the index level concept within finance, including its purpose, simple interpretation, and common applications.
17,472 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
March could reveal a powerful momentum move for a marquee AI stock. Learn why this genius stock that could surge on A...
Seasonal 13F filings shed light on big moves by top money managers. This article breaks down a notable shift: billion...
Stocks retreat as Novo Nordisk and Jefferies face analyst downgrades, while Talkspace advances toward a private-equit...
A hedge fund made a sizable new bet on Centuri Holdings, disclosed in an SEC filing. This article breaks down the num...
March 2026 sees a surge in MetaStock alternatives as traders seek real-time data, AI insights, and cloud-based tools....
Analysts raise the oracle price target $240 after Oracle reports resilient AI cloud demand and stronger-than-expected...
A top executive recently disclosed selling a sizable block of Qualys stock. This article explains how to interpret in...
Oil volatility could create a rare buy-on-dip window for memory names. Jim Cramer says Western Digital and Micron may...
As mortgage rates shift and originations evolve, loandepot (LDI) 2025 earnings will hinge on rate flow, loan mix, and...
Bitcoin steadies near the $70,000 mark as oil prices leap and geopolitical tensions rise. Analysts weigh whether the ...
As 2026 AI demand shifts, investors weigh TSMC and AMD on who can sustain capacity, pricing power, and growth. This p...